核醫影像設備市場規模、佔有率、成長分析、按產品、按應用、按最終用戶、按地區 - 產業預測，2024-2031年

2022年全球核醫影像設備市場規模為30.2億美元，預計從2023年的32.5億美元成長到2031年的57.5億美元，在預測期內（2024-2031年）年複合成長率為7.41%。

由於技術進步和對提高診斷準確性的日益關注，核醫學影像設備市場預計將顯著成長。包括 PET/MRI 和 PET/CT 在內的混合成像系統等創新增強了功能，可以更準確地可視化和診斷各種放射性狀況。隨著慢性病的流行和醫療保健支出的增加，對這些先進診斷影像工具的需求不斷增加。然而，市場面臨著監管障礙和與使用放射性材料相關的高成本等挑戰。儘管存在這些障礙，但充滿希望的成長機會出現，特別是隨著監管機構簡化新技術的核准流程以及醫療保健行業致力於改善患者體驗。隨著放射性藥物開發的進步以及人們對及時準確診斷重要性的日益認知，核醫學影像市場預計在未來幾年將顯著成長。總體而言，創新成像解決方案和改進的以患者為中心的方法的整合預計將塑造醫療保健這一重要領域的未來。

目錄

介紹

• 研究目的
• 定義
• 市場範圍

調查方法

• 資訊採購
• 二手資料來源和主要資料來源
• 市場規模預測
• 市場假設與限制

執行摘要

• 市場概況展望
• 供需趨勢分析
• 依細分市場的機會分析

市場動態及展望

• 市場動態
  • 促進因素
  • 機會
  • 抑制因素
  • 課題
• 波特的分析

主要市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 價格分析
• 價值鏈分析
• 供應鏈分析

核子醫學影像設備市場：依產品分類

• 市場概況
• 單光子發射電腦斷層掃描（SPECT）影像系統
  • 混合SPECT 影像系統
  • 獨立SPECT影像系統
• 混合PET成像系統
• 平面閃爍掃描成像系統

核子醫學影像設備市場：依應用分類

• 市場概況
• 瘤
• 心臟病
• 神經
• 其他用途

核子醫學影像設備市場：依最終用戶分類

• 市場概況
• 醫院
• 形像中心
• 學術研究中心
• 其他最終用戶

核子醫學影像設備市場：依地區

• 市場概況
• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地區
• 中東和非洲（MEA）
  • 海灣合作理事會國家
  • 南非
  • 其他中東、非洲地區

競爭格局

• 前5名企業對比
• 主要企業市場定位（2023年）
• 主要市場參與者所採取的策略
• 近期市集活動
• 主要企業市場佔有率（2023年）

主要企業簡介

• Siemens AG
• General Electric
• Koninklijke Philips NV
• TTG Imaging Solutions
• Neusoft Corporation
• Canon Inc.
• Surgiceye GmbH
• Bozlu Holding
• CMR Naviscan Corporation
• Mediso Ltd.
• Shimadzu Corporation
• Revvity Inc
• Rigaku
• MR Solutions Ltd.
• Agfa-Gevaert NV
• Medtronic plc
• Bracco Group
• Cubresa Inc.
• Jubilant Radiopharma
• South African Nuclear Energy Corporation（Necsa）

Global Nuclear Imaging Equipment Market size was valued at USD 3.02 billion in 2022 and is poised to grow from USD 3.25 billion in 2023 to USD 5.75 billion by 2031, growing at a CAGR of 7.41% during the forecast period (2024-2031).

The nuclear imaging equipment market is poised for significant growth, driven by advancements in technology and an increased focus on improving diagnostic accuracy. Innovations such as hybrid imaging systems, including PET/MRI and PET/CT, are enhancing functionality, allowing for more precise visualization and diagnosis of various medical conditions using radioactive materials. As chronic diseases become more prevalent and healthcare expenditures rise, the demand for these sophisticated imaging tools is on the rise. However, the market faces challenges, including regulatory hurdles and the high costs associated with the use of radioactive substances. Despite these obstacles, there are promising opportunities for growth, particularly as regulatory bodies simplify the approval process for new technologies and as the healthcare sector places greater emphasis on enhancing patient experience. With ongoing developments in radiopharmaceuticals and an increasing recognition of the importance of timely and accurate diagnostics, the nuclear imaging equipment market is set to experience substantial advancements in the coming years. Overall, the integration of innovative imaging solutions and improved patient-centric approaches is expected to shape the future of this vital sector in healthcare.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Nuclear Imaging Equipment market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Nuclear Imaging Equipment Market Segmental Analysis

Global Nuclear Imaging Equipment Market is segmented by Product, Application, End User, and Region. Based on Product, the market is segmented into Single-Photon Emission Computed Tomography (SPECT) Imaging Systems (Hybrid SPECT Imaging Systems, Standalone SPECT Imaging Systems), Hybrid PET Imaging Systems, Planar Scintigraphy Imaging Systems. Based on Application, the market is segmented into Oncology, Cardiology, Neurology, Other Applications. Based on End User, the market is segmented into Hospitals, Imaging Centers, Academic & Research Centers, Other End Users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Nuclear Imaging Equipment Market

The Global Nuclear Imaging Equipment market is significantly driven by the emergence of hybrid systems like PET/MRI and PET/CT, which seamlessly integrate various imaging modalities to deliver unparalleled precision and comprehensive diagnostic information. This convergence of technologies not only improves imaging accuracy but also broadens the scope of conditions that can be diagnosed through nuclear imaging, thereby elevating awareness and clinical significance among healthcare providers and patients alike. Furthermore, advancements in radiopharmaceuticals have refined the imaging process, enhancing the efficacy and reliability of diagnoses, thus contributing robustly to the growth trajectory of the nuclear imaging market.

Restraints in the Global Nuclear Imaging Equipment Market

The Global Nuclear Imaging Equipment market faces significant restraints primarily due to the intricate and constrained development of radiopharmaceuticals essential for imaging procedures. Challenges related to production capacity and supply chain logistics can lead to critical shortages of these vital substances, hindering their availability in the market. Additionally, the inherent short half-lives of most radiopharmaceuticals necessitate rapid manufacturing and distribution, compounding the difficulty in meeting demand. Such complexities in production and quality control processes not only limit the supply of nuclear imaging agents but also pose substantial delays, ultimately restricting the overall growth potential of the nuclear imaging equipment sector.

Market Trends of the Global Nuclear Imaging Equipment Market

The Global Nuclear Imaging Equipment market is witnessing a notable trend driven by advancements in radiopharmaceuticals that enhance diagnostic capabilities across various diseases. Innovations in novel tracers are facilitating the detection of complex conditions such as cancer, cardiovascular diseases, and neurological disorders. Moreover, the rise of theragnostic approaches-integrating targeted therapy with diagnostic imaging-is gaining traction, particularly in oncology, allowing for personalized treatment plans. This convergence of diagnostics and therapeutics is expected to augment market growth, as healthcare providers increasingly adopt these advanced technologies to improve patient outcomes and streamline treatment processes, ultimately reshaping the landscape of medical imaging.

Table of Contents

Introduction

• Objectives of the Study
• Definitions
• Market Scope

Research Methodology

• Information Procurement
• Secondary & Primary Data Sources
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Market Overview Outlook
• Supply Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factor
• Degree of Competition
• Top Investment Pockets
• Ecosystem of the Market
• Pricing Analysis
• Value Chain Analysis
• Supply Chain Analysis

Nuclear Imaging Equipment Market, By Product

• Market Overview
• Single-Photon Emission Computed Tomography (SPECT) Imaging Systems
  • Hybrid SPECT Imaging Systems
  • Standalone SPECT Imaging Systems
• Hybrid PET Imaging Systems
• Planar Scintigraphy Imaging Systems

Nuclear Imaging Equipment Market, By Application

• Market Overview
• Oncology
• Cardiology
• Neurology
• Other Applications

Nuclear Imaging Equipment Market, By End User

• Market Overview
• Hospitals
• Imaging Centers
• Academic & Research Centers
• Other End Users

Nuclear Imaging Equipment Market Size by Region

• Market Overview
• North America
  • USA
  • Canada
• Europe
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Rest of Latin America
• Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA

Competitive Landscape

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Activities in the Market
• Key Companies Market Share (%), 2023

Key Company Profiles

• Siemens AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• General Electric
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Koninklijke Philips N.V.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• TTG Imaging Solutions
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Neusoft Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Canon Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Surgiceye GmbH
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bozlu Holding
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CMR Naviscan Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mediso Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Shimadzu Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Revvity Inc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Rigaku
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MR Solutions Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agfa-Gevaert N.V
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic plc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bracco Group
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cubresa Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Jubilant Radiopharma
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• South African Nuclear Energy Corporation (Necsa)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments